Akagera’s Drug Development Process for Liposomal Oxazolidinones — AKAGERA Medicines

AKAGERA Medicines

HOME Mission Statement

SCIENCE TEAM BOARD OF DIRECTORS AKAGERA MEDICINES, AFRICA SCIENCE ADVISORY BOARD BUSINESS ADVISORY BOARD A Letter About Joe Ritchie & Paul Farmer A Note on our Multi-Culture The Interns

Strategy, Partners, Product Pipeline, IP Tuberculosis MRSA Vaccine Delivery System Drug Development Process

Presentations, Podcasts & ARTICLES BIBLIOGRAPHY A Brief History of TB Recent Rwandan Developments Rwandan Leadership Conference

General Contact INVESTOR COMMUNICATION

HOME Mission Statement PEOPLE SCIENCE TEAM BOARD OF DIRECTORS AKAGERA MEDICINES, AFRICA SCIENCE ADVISORY BOARD BUSINESS ADVISORY BOARD A Letter About Joe Ritchie & Paul Farmer A Note on our Multi-Culture The Interns SCIENCE Strategy, Partners, Product Pipeline, IP Tuberculosis MRSA Vaccine Delivery System Drug Development Process NEWS & PUBLICATIONS Presentations, Podcasts & ARTICLES BIBLIOGRAPHY A Brief History of TB Recent Rwandan Developments Rwandan Leadership Conference CONTACT General Contact INVESTOR COMMUNICATION

AKAGERA Medicines

a Rwandan Biotech

Akagera’s Drug Development Process for Liposomal Oxazolidinones

AKAGERA Medicines: 271 Waverly Oaks Road | Waltham, MA 02452